Back

Transthyretin amyloid cardiomyopathy in a southeast asian population

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - epidemiology, prognosis, outcome (3) Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Weixian Alex Tan

National Heart Centre Singapore, Singapore (Singapore)

6 More presentations in this session

Presentation thumbnail
Sex-related differences in rehospitalization rates of patients with heart failure with preserved and mildly reduced ejection fraction with and without diabetes
Doctor F. Stoiculescu (Craiova, RO)
Abstract Slides Video
Presentation thumbnail
Sex-based differences in the impact of nutritional status on in-hospital mortality in patients with heart failure with preserved ejection fraction (HFpEF)
Associate Professor M. Czapla (Wroclaw, PL)
Abstract Slides Video
Presentation thumbnail
Uncovering the heart of Mexico: clinical insights into Heart Failure patterns, causes, and outcomes
Doctor R. Lozano Corral (Ciudad de Mexico, MX)
Abstract Slides Video
Presentation thumbnail
Uncovering predictors of adverse outcomes in HFrEF after acute myocardial infarction
Doctor J. Fernandes Pedro (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Waist-to-height ratio as a predictor of incident heart failure
Doctor A. Jujic (Malmo, SE)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - epidemiology, prognosis, outcome (3)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Temporal trends and clinical characteristics of variant versus wild-type transthyretin amyloid cardiomyopathy in Asian population: the Korean nationwide cohort study
thumbnail
Congress Presentation
Clinical characteristics, mortality outcomes and survival predictors of transthyretin cardiac amyloidosis in an Asian registry
thumbnail
Congress Presentation
Transthyretin amyloid cardiomyopathy (ATTR-CM) cardiogenomics: a tertiary centre experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources